Synthesis and Antiviral Activity of Some (3,4-Diaryl-3H-thiazol-2-ylidene)pyrimidin-2-yl Amine Derivatives
暂无分享,去创建一个
[1] A. H. Moustafa,et al. Synthesis of Some New Pyrimidine Derivatives of Expected Antimicrobial Activity , 2007 .
[2] M. Tausek,et al. 2′-C-Methyl Branched Pyrimidine Ribonucleoside Analogues: Potent Inhibitors of RNA Virus Replication , 2007, Antiviral chemistry & chemotherapy.
[3] Ying Guo,et al. Synthesis of 1‐(Alkyl)‐5‐dimethylamino‐6‐phenethyluracils as Potent Nonnucleoside HIV‐1 RT Inhibitors , 2007 .
[4] B. Kalluraya,et al. Synthesis and Biological Study of Some Novel 4-[5-(4,6-Disubstituted-2-thiomethylpyrimidyl)-4′-amino-1,2,4- triazol-3′-yl] thioacetyl-3-arylsydnones , 2007 .
[5] Ying Guo,et al. Synthesis of l‐(Alkoxymethyl)‐5‐benzyl‐6‐methyluracil as Potential Nonnucleoside HIV‐1 RT Inhibitors , 2006 .
[6] Marcus V. N. Souza. Synthesis and biological activity of natural thiazoles: An important class of heterocyclic compounds , 2005 .
[7] M. Fontecave,et al. Biological radical sulfur insertion reactions. , 2003, Chemical reviews.
[8] Z. Kaplancıklı,et al. Synthesis and antimicrobial activity of some pyridinyliminothiazoline derivatives. , 2002, Farmaco.
[9] E. De Clercq,et al. SYNTHESIS, ANTIVIRAL AND CYTOSTATIC ACTIVITIES, OF CARBOCYCLIC NUCLEOSIDES INCORPORATING A MODIFIED CYCLOPENTANE RING. IV. ADENOSINE AND URIDINE ANALOGUES , 2002, Nucleosides, nucleotides & nucleic acids.
[10] M. T. Aal. SYNTHESIS OF SOME NEW S-DABO AND HEPT ANALOGUES WITH EXPECTED BIOLOGICAL ACTIVITY AGAINST HBV , 2002 .
[11] E. De Clercq,et al. SYNTHESIS AND ANTI-HIV ACTIVITY OF NEW MODIFIED 1,2,3-TRIAZOLE ACYCLONUCLEOSIDES , 2001, Nucleosides, nucleotides & nucleic acids.
[12] K. Kato,et al. Sugar-modified nucleosides in past 10 years, a review. , 2001, Current medicinal chemistry.
[13] M. Kidwai,et al. Novel one pot synthesis of new pyranopyrimidines using microwaves† , 2000 .
[14] M. Andreola,et al. Synthesis and evaluation of oligo-1,3-thiazolecarboxamide derivatives as HIV-1 reverse transcriptase inhibitors. , 2000, Bioorganic & medicinal chemistry.
[15] T. Woltering,et al. Structure-activity relationships of substituted 5H-thiazolo[3,2-a]pyrimidines as group 2 metabotropic glutamate receptor antagonists. , 1999, Bioorganic & medicinal chemistry letters.
[16] C. Kappe,et al. Conformational analysis of 4-aryl-dihydropyrimidine calcium channel modulators. A comparison of ab initio, semiempirical and X-ray crystallographic studies , 1997 .
[17] L. Overman,et al. Enantioselective Total Synthesis of (-)-Ptilomycalin A , 1995 .
[18] H. Ishikawa,et al. Synthesis and anti-pseudomonal activity of new 2-isocephems with a dihydroxypyridone moiety at C-7 , 1994 .
[19] C. Kappe. 100 years of the biginelli dihydropyrimidine synthesis , 1993 .
[20] A Hedberg,et al. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents. , 1991, Journal of medicinal chemistry.
[21] A. Fauci,et al. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.
[22] J. Sidtis,et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.
[23] E. Clercq. Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS). , 1986 .